Article

Exploring the Therapeutic Mechanisms and Prognostic Targets of Biochanin A in Glioblastoma via Network Pharmacology and Bioinformatics Analysis

2023-10-19

Abstract excerpt

<h4>Purpose: </h4> Glioblastoma (GBM) is the most malignant type of brain tumor, characterized by a poor prognosis and high recurrence and mortality rates. Biochanin A (BCA) has demonstrated promising clinical antitumor effects. This study aimed to explore the pharmacological mechanisms by which BCA acts against GBM. Methods Network pharmacology was employed to identify overlapping target genes between BCA and GB...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a0cc6e3f-36c3-5ed4-abc6-cbd0883a0631
DOI: 10.21203/rs.3.rs-3439637/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring the Therapeutic Mechanisms and Prognostic Targets of Biochanin A in Glioblastoma via Network Pharmacology and Bioinformatics AnalysisDOI 10.21203/rs.3.rs-3439637/v1Read

Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experimentsSemantic proximity Read

Identification of potential biomarkers and candidate small molecule drugs in glioblastomaSemantic proximity Read

Identification of Potential Therapeutic Targets and Biomarkers for Glioblastomas Through Integrative Analysis of Gene Expression DataSemantic proximity Read

Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysisSemantic proximity Read

Key Genes Are Associated with the Prognosis of Glioma, and Melittin Can Regulate the Expression of These Genes in Glioma U87 CellsSemantic proximity Read

Identification of new targets for glioblastoma therapy based on a DNA expression microarraySemantic proximity Read

The identification of key genes and pathways in glioblastoma by bioinformatics analysisSemantic proximity Read

Bioinformatics analysis of KIF20A, a potential therapeutic target for glioblastomaSemantic proximity Read

Systematic analysis of potential targets of the curcumin analog pentagamavunon-1 (PGV-1) in overcoming resistance of glioblastoma cells to bevacizumabSemantic proximity Read

Comprehensive analysis reveals independent prognostic biomarkers in glioblastomaSemantic proximity Read

Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic ValueSemantic proximity Read

Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic AnalysisSemantic proximity Read